SC
TECX

Steven Cohen’s Tectonic Therapeutic TECX Stock Holding History

Steven Cohen’s Portfolio TECX Stock Details TECX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-68,598
Closed -$2.12M – 4688
2026
Q1 		$2.12M Sell
68,598
-423,734
-86% -$10.4M ﹤0.01% 2269
2025
Q4 		$10.3M Buy
492,332
+70,577
+17% +$1.31M 0.01% 1340
2025
Q3 		$6.62M Buy
421,755
+190,723
+83% +$3.94M 0.01% 960
2025
Q2 		$4.59M Buy
231,032
+31,032
+16% +$629K 0.01% 1006
2025
Q1 		$3.54M Buy
+200,000
New +$6.52M 0.01% 1054
2023
Q2 		– Sell
-54,167
Closed -$650K – 2877
2023
Q1 		$650K Buy
+54,167
New +$754K ﹤0.01% 1183
2022
Q1 		– Sell
-12,500
Closed -$578K – 1432
2021
Q4 		$578K Sell
12,500
-6,667
-35% -$383K ﹤0.01% 958
2021
Q3 		$1.28M Sell
19,167
-23,750
-55% -$1.95M 0.01% 830
2021
Q2 		$4.58M Buy
42,917
+9,484
+28% +$1.12M 0.02% 622
2021
Q1 		$5.09M Buy
+33,433
New +$5.44M 0.02% 564

Other funds holding TECX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $288M AUM 313.93% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return

Steven Cohen's TECX Position: Q2 2026 in Review

Steven Cohen sold out of Tectonic Therapeutic (TECX) in Q2 2026, closing a stake of 68,598 shares — an estimated $2.12M sold.

Steven Cohen first reported a position in TECX in Q1 2021 and held it in 10 quarters. The position peaked at $10.3M in Q4 2025. 122 funds tracked by Wall St. Rank hold TECX as of Q2 2026.

  • Steven Cohen reported no remaining Tectonic Therapeutic position as of Q2 2026 after selling out during the quarter.
  • Steven Cohen sold 68,598 Tectonic Therapeutic shares in Q2 2026, an estimated $2.12M.
  • Steven Cohen first reported a position in Tectonic Therapeutic in Q1 2021 and held it in 10 quarters.
  • Steven Cohen's Tectonic Therapeutic position peaked at $10.3M in Q4 2025.
  • 122 funds tracked by Wall St. Rank held Tectonic Therapeutic as of Q2 2026.

Based on Point72 Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.